Evidence map›Paper›PMID 40947711›Full record

SynthesisCurrent medicinal chemistry2026

[

Xinmin Wang, Yufei Xu, Jing Jing

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xinmin WangDepartment of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yufei XuState Key Laboratory of Biotherapy, Institute for Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Jing JingState Key Laboratory of Biotherapy, Institute for Breast Health Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBreast cancer has become the most commonly diagnosed cancer in women worldwide, with advanced cases often leading to bone metastases that significantly affect prognosis and quality of life. This meta-analysis and systematic review aims to evaluate and compare the diagnostic performance of [

methodsA systematic search was conducted across PubMed, Embase, Web of Science, and Scopus for studies published up to February 2025. Relevant articles were identified using a combination of subject-specific and free-text keywords, including "breast cancer," "positron emission tomography," "bone scintigraphy," and "bone metastasis." Studies assessing the diagnostic utility of [

resultsA total of 1407 publications were initially retrieved, and 13 studies involving 892 patients met the inclusion criteria. The pooled diagnostic performance for [ DISCUSSION: Our meta-analysis demonstrated the superior diagnostic performance of [

conclusionThe findings suggest that [

Indexed as

Bone and BonesBone NeoplasmsBreast NeoplasmsFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyRadiopharmaceuticalsFemaleHumansRadionuclide ImagingFluorodeoxyglucose F18Radiopharmaceuticalsbone metastasisbone scintigraphybreast cancerconfidence intervalsosteoclastsPET/CT

Identifiers

PMID40947711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.